Table 2.

Demographic variables, clinical features, diagnostic and treatment approaches of our COVID-19 patients with autoinflammatory diseases

	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6	Patient 7
Age (years)	18.8	3.8	17.5	17.4	10.9	20.1	18.1
Gender	Female	Male	Male	Male	Female	Male	Female
Diagnosis	FMF	PFAPA	FMF	FMF	FMF	FMF	FMF
Source of contact	Father, mother and two other siblings	Not a family member	Father, mother	Father, mother and one sibling	Father, mother	Father, mother and one sibling	Father, mother
Treatments they were on	Colchicine	None	Colchicine	Colchicine	Colchicine	Colchicine	Colchicine
Number of disease flares during pandemic	6	3	2	1	0	0	0
Symptoms	Fever, dry cough, sore throat, diarrhea	None	Fever, dry cough, sore throat, dyspnea, diarrhea, myalgia	Fever, dry cough, diarrhea	None	Fever, sore throat	Fever, dry cough, sore throat, diarrhea, myalgia
Chest CT	Air bronchograms, ground-glass opacities	Not performed	Normal	Normal	Normal	Halo sign	Normal
Follow-up way	Outpatient clinic and/or via phone	Outpatient clinic and/or via phone	Outpatient clinic and/or via phone	Outpatient clinic and/or via phone	Outpatient clinic and/or via phone	Outpatient clinic and/or via phone	Hospitalized for 5 days
Prescribed medication	Azithromycin Oseltamivir HCQ	None	Azithromycin Oseltamivir HCQ	Azithromycin Oseltamivir HCQ	None	HCQ	Oseltamivir HCQ
Current situation	Asymptomatic	Asymptomatic	Asymptomatic	Asymptomatic	Asymptomatic	Asymptomatic	Asymptomatic

CT computed tomography, FMF familial mediterranean fever, HCQ hydroxychloroquine, PFAPA periodic fever aphthous stomatitis pharyngitis and adenopathy